Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Zytiga

Abiraterone Acetate

Open in the dashboard

Part D claims

1,093

Prescriptions dispensed, refills included

Drug cost

$11,471,290

Paid at the pharmacy, in all

Prescribers

77

With 11 or more claims of it

In 2024, Medicare Part D recorded 1,093 claims for Zytiga (abiraterone acetate) from 77 prescribers, at a total drug cost of $11.5 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 30 states and territories
Part D claims for Zytiga by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 11 151 $1,658,117
NY 11 148 $1,614,517
PR 6 89 $971,462
SC 3 67 $806,526
FL 4 56 $556,381
PA 3 51 $504,467
TX 4 49 $517,062
NC 4 49 $457,537
WV 3 43 $474,477
OR 3 40 $375,470
CT 3 35 $394,271
VA 2 28 $299,879
IL 2 27 $285,893
NJ 2 26 $285,489
MS 1 26 $288,008
The other 15 states and territories
State Prescribers Claims Drug cost
KY 1 24 $245,447
WA 1 20 $135,444
MI 1 17 $89,442
AZ 1 15 $167,750
OH 1 14 $154,261
GA 1 14 $153,191
MA 1 13 $141,262
HI 1 12 $131,764
WI 1 12 $65,880
LA 1 12 $103,376
MD 1 11 $119,854
IN 1 11 $126,624
AR 1 11 $107,690
TN 1 11 $123,100
MO 1 11 $116,649

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 7 of 7
Part D claims for Zytiga by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Hematology-Oncology 29 397 $4,013,732
Urology 20 270 $3,097,133
Medical Oncology 12 176 $1,837,857
Nurse Practitioner 12 158 $1,686,579
Physician Assistant 1 35 $360,977
Internal Medicine 2 29 $221,206
Hematopoietic Cell Transplantation and Cellular Therapy 1 28 $253,807

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 77 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Pooja Patel Physician Assistant SC 35 $360,977 None on record
Matthew Zibelman Hematopoietic Cell Transplantation and Cellular Therapy PA 28 $253,807 None on record
Dania Santiago Caraballo Hematology-Oncology PR 27 $292,354 None on record
Patrick Daily Urology MS 26 $288,008 None on record
Arash Rezazadeh Kalebasty Hematology-Oncology CA 25 $271,347 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 77 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for abiraterone acetate

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record